structural variants in multiple myeloma: impact on outcomes & potential drug targets
Published 2 years ago • 79 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
2:00
the role of small nucleotide, copy number and structural variants in extramedullary myeloma
-
1:43
real-world outcomes of teclistamab for r/r multiple myeloma
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
2:48
novel targets in multiple myeloma
-
0:59
defining the origins of multiple myeloma
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
0:40
the impact of an evolving first-line setting on subsequent treatment lines in multiple myeloma
-
21:38
drawing the line: the rationale behind blood tube collection order
-
10:20
understanding multiple myeloma (multiple myeloma explained clearly)
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:43
multiomic mapping of aberrations on chromosome 1 in myeloma
-
1:53
the future of multiple myeloma treatment
-
2:24
the importance of molecular testing in multiple myeloma and how this may impact future treatment
-
2:13
founding precision therapy for 1q-amplified multiple myeloma
-
3:00
current & emerging biomarkers in multiple myeloma
-
4:56
genome sequencing in multiple myeloma
-
9:32
multiple myeloma: genomic evolution
-
2:49
how is the genomic landscape of multiple myeloma changing?
-
5:02
drug resistance in multiple myeloma